Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Nóra Meggyesi
Observed names:
Meggyesi, Nora,
Meggyesi, Nóra,
N Meggyesi,
N. Meggyesi,
Nora Meggyesi
Institution:
Jahn Ferenc Dél-Pesti Kórház és Rendelőintézet
Observed institutions:
Institut Gustave Roussy,
Országos Gyógyintézeti Központ,
Hungarian National Blood Transfusion Service,
National Blood Transfusion Service,
Jahn Ferenc Dél-Pesti Kórház és Rendelőintézet,
National Blood Transfusion Service,
National Blood Service Ghana
show all 7
OpenAlex ID:
A5066175900
Standardization of molecular monitoring of CML: results and recommendations from the European treatment and outcome study
2022
·
Helen E. White
, Matthew Salmon
, et al.
·
Leukemia
·
62
Type and location of isocitrate dehydrogenase mutations influence clinical characteristics and disease outcome of acute myeloid leukemia
2012
·
Magdalena Koszarska
, Andras Bors
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
34
Additional Chromosome Abnormalities, BCR-ABL Tyrosine Kinase Domain Mutations and Clinical Outcome in Hungarian Tyrosine Kinase Inhibitor-Resistant Chronic Myelogenous Leukemia Patients
2011
·
Nóra Meggyesi
, András Kozma
, et al.
·
Acta Haematologica
·
32
JAK2 46/1 haplotype analysis in myeloproliferative neoplasms and acute myeloid leukemia
2010
·
H Andrikovics
, S Nahajevszky
, et al.
·
Leukemia
·
32
Current Trends in Applications of Circulatory Microchimerism Detection in Transplantation
2019
·
Hajnalka Andrikovics
, Zoltán Őrfi
, et al.
·
International Journal of Molecular Sciences
·
31
PDF
The prognostic impact of germline 46/1 haplotype of Janus kinase 2 in cytogenetically normal acute myeloid leukemia
2011
·
S. Nahajevszky
, H. Andrikovics
, et al.
·
Haematologica
·
22
PDF
NKX2-3 and IRGM variants are associated with disease susceptibility to IBD in Eastern European patients
2010
·
Nora Meggyesi
, Lajos S Kiss
, et al.
·
World Journal of Gastroenterology
·
22
PDF
Medium-sizedFLT3internal tandem duplications confer worse prognosis than short and long duplications in a non-elderly acute myeloid leukemia cohort
2013
·
Magdalena Koszarska
, Nora Meggyesi
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
20
HFEC282Y Mutation as a Genetic Modifier Influencing Disease Susceptibility for Chronic Myeloproliferative Disease
2009
·
Hajnalka Andrikovics
, Nora Meggyesi
, et al.
·
Cancer Epidemiology Biomarkers & Prevention
·
16
PDF
Proteasome Subunit Beta Type 1 P11A Polymorphism Is a New Prognostic Marker in Multiple Myeloma
2017
·
Gergely Varga
, Gábor Mikala
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
·
13
PDF
Effective virus-specific T-cell therapy for high-risk SARS-CoV-2 infections in hematopoietic stem cell transplant recipients: initial case studies and literature review
2023
·
László Gopcsa
, Marienn Réti
, et al.
·
GeroScience
·
12
PDF
Role of the activating mutation Val617Phe of Janus kinase 2 gene in myeloproliferative diseases and significance of its detection
2007
·
Hajnalka Andrikovics
, Anikó Szilvási
, et al.
·
Orvosi Hetilap
·
12
Results of the European survey on the assessment of deep molecular response in chronic phase CML patients during tyrosine kinase inhibitor therapy (EUREKA registry)
2019
·
Susanne Möbius
, Thomas Schenk
, et al.
·
Journal of Cancer Research and Clinical Oncology
·
11
Characterization of ABL exon 7 deletion by molecular genetic and bioinformatic methods reveals no association with imatinib resistance in chronic myeloid leukemia
2011
·
Nóra Meggyesi
, Lajos Kalmár
, et al.
·
Medical Oncology
·
9
Complex molecular genetic diagnostic algorithm in the diagnosis of myeloproliferative neoplasms
2014
·
Tünde Krähling
, Katalin Balassa
, et al.
·
Orvosi Hetilap
·
4
PDF
Investigation of TGFB1 −1347C>T variant as a biomarker after allogeneic hematopoietic stem cell transplantation
2019
·
Petra Kövy
, Nóra Meggyesi
, et al.
·
Bone Marrow Transplantation
·
2
Új terápiás célpont akut myeloid leukémiában: izocitrát dehidrogenáz 1 és 2 mutációk
2019
·
Petra Kövy
, András Kozma
, et al.
·
Hematológia–Transzfuziológia
·
2
PDF
Adoptive T-cell therapies for persistent COVID-19 in immunocompromised patients: Comparison of IFN-γ virus-specific T-cell therapy and CD45RA+ T-cell depleted donor lymphocyte infusion
2026
·
László Gopcsa
, Borisz Rabán Petrik
, et al.
·
GeroScience
·
1
PDF
Microchimaerismus kimutatása nagy érzékenységű droplet digitális PCR technikával és szerepe a vérképzőőssejt-transzplantált betegek monitorozásában
2024
·
Zoltán Őrfi
, Nóra Meggyesi
, et al.
·
Orvosi Hetilap
·
1
Kimérizmusvizsgálatok jelentősége allogén hematopoetikus őssejt-transzplantációt követően
2020
·
Nóra Meggyesi
, Hajnalka Andrikovics
, et al.
·
Hematológia–Transzfuziológia
·
1
The adverse effect of FOPNL genomic variant is reversed by bortezomib-based treatment protocols in multiple myeloma
2017
·
Katalin Piroska Kiss
, Gergely Varga
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
1
P119 Clinical characteristics of JAK2 V617F positive myeloproliferative diseases
2007
·
H. Andrikovics
, A. Szilvasi
, et al.
·
Blood Reviews
·
1
Allogeneic hematopoietic stem cell transplantation in cutaneous T-cell lymphoma – A rarely applied but potentially curative therapeutic option
2025
·
Alexandra Raska
, László Gopcsa
, et al.
·
Bőrgyógyászati és Venerológiai Szemle
PDF
[The role of clonal hematopoiesis in the molecular diagnostics of solid tumors].
2024
·
Zoltán Őrfi
, Attila Kállai
, et al.
·
Europe PMC (PubMed Central)
PDF
Két myeloproliferativ betegség egy betegben – klónok együttélése és vetélkedése
2022
·
Sándor Fekete
, Judit Reichardt
, et al.
·
Orvosi Hetilap
PDF
Show more works
View as search
Works count:
37
Citation count:
341
H-index:
11
I10-index:
13
Year
Topic
Type